AMYLIN PHARMACEUTICALS INC Comprehensive Income
AMYLIN PHARMACEUTICALS INC reported Comprehensive Income of -$74.21 million for the 3-month period ending 2012-06-30, per its 10-Q filed 2012-08-03.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2012-08-03
- AMYLIN PHARMACEUTICALS INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2012-06-30 was -$74.21M.
- AMYLIN PHARMACEUTICALS INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2012-03-31 was -$97.71M.
- AMYLIN PHARMACEUTICALS INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2011-09-30 was -$14.54M.
- AMYLIN PHARMACEUTICALS INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2011-06-30 was -$31.25M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month |
|---|---|---|---|
| 2012-06-30 | -$74.21M 10-Q · filed 2012-08-03 | -$171.93M 10-Q · filed 2012-08-03 | |
| 2012-03-31 | -$97.71M 10-Q · filed 2012-05-07 | ||
| 2011-09-30 | -$14.54M 10-Q · filed 2011-10-28 | -$45.79M derived: sum of 2 quarters · filed 2012-08-03 | -$83.02M 10-Q · filed 2011-10-28 |
| 2011-06-30 | -$31.25M 10-Q · filed 2012-08-03 | -$68.48M 10-Q · filed 2012-08-03 | |
| 2011-03-31 | -$37.23M 10-Q · filed 2012-05-07 | ||
| 2010-09-30 | -$49.98M 10-Q · filed 2011-10-28 | -$94.48M derived: sum of 2 quarters · filed 2011-10-28 | -$131.96M 10-Q · filed 2011-10-28 |
| 2010-06-30 | -$44.50M 10-Q · filed 2011-08-08 | -$81.98M 10-Q · filed 2011-08-08 |